Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtOther Non-Current AssetsPayablesPreferred SharesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Banc Of California (BANC-PF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Banc Of California (BANC-PF) over the last 14 years, with Q3 2025 value amounting to $2.4 billion.

  • Banc Of California's Cash & Equivalents fell 610.6% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year decrease of 610.6%. This contributed to the annual value of $2.5 billion for FY2024, which is 5346.95% down from last year.
  • According to the latest figures from Q3 2025, Banc Of California's Cash & Equivalents is $2.4 billion, which was down 610.6% from $2.4 billion recorded in Q2 2025.
  • Over the past 5 years, Banc Of California's Cash & Equivalents peaked at $6.7 billion during Q2 2023, and registered a low of $163.3 million during Q2 2021.
  • For the 5-year period, Banc Of California's Cash & Equivalents averaged around $2.7 billion, with its median value being $2.4 billion (2025).
  • Per our database at Business Quant, Banc Of California's Cash & Equivalents tumbled by 6117.06% in 2021 and then soared by 265571.33% in 2023.
  • Over the past 5 years, Banc Of California's Cash & Equivalents (Quarter) stood at $4.1 billion in 2021, then tumbled by 44.78% to $2.2 billion in 2022, then soared by 140.05% to $5.4 billion in 2023, then tumbled by 53.47% to $2.5 billion in 2024, then dropped by 4.15% to $2.4 billion in 2025.
  • Its Cash & Equivalents was $2.4 billion in Q3 2025, compared to $2.4 billion in Q2 2025 and $2.3 billion in Q1 2025.